| Efficacy and safety of vismodegib in advanced basal-cell carcinoma A Sekulic, MR Migden, AE Oro, L Dirix, KD Lewis, JD Hainsworth, ... New England Journal of Medicine 366 (23), 2171-2179, 2012 | 1716 | 2012 |
| Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2–negative metastatic … DW Miles, A Chan, LY Dirix, J Cortés, X Pivot, P Tomczak, T Delozier, ... Journal of clinical oncology 28 (20), 3239-3247, 2010 | 1102 | 2010 |
| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ... The lancet oncology 15 (4), 406-414, 2014 | 977 | 2014 |
| Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, ... European Journal of Cancer 32 (14), 2474-2484, 1996 | 948 | 1996 |
| Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial M Kaufmann, E Bajetta, LY Dirix, LE Fein, SE Jones, N Zilembo, ... Journal of Clinical Oncology 18 (7), 1399-1411, 2000 | 690 | 2000 |
| Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours PB Vermeulen, G Gasparini, SB Fox, C Colpaert, LP Marson, M Gion, ... European journal of cancer 38 (12), 1564-1579, 2002 | 644 | 2002 |
| Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer HJ Burstein, Y Sun, LY Dirix, Z Jiang, R Paridaens, AR Tan, A Awada, ... Journal of Clinical Oncology 28 (8), 1301-1307, 2010 | 643 | 2010 |
| Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer R Salgado, S Junius, I Benoy, P Van Dam, P Vermeulen, E Van Marck, ... International journal of cancer 103 (5), 642-646, 2003 | 598 | 2003 |
| Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel M Aapro, PA Abrahamsson, JJ Body, RE Coleman, R Colomer, L Costa, ... Annals of oncology 19 (3), 420-432, 2008 | 592 | 2008 |
| International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ... Annals of oncology 22 (3), 515-523, 2011 | 558 | 2011 |
| Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse M Brada, K Hoang-Xuan, R Rampling, PY Dietrich, LY Dirix, D Macdonald, ... Annals of Oncology 12 (2), 259-266, 2001 | 482 | 2001 |
| Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer SA Hurvitz, L Dirix, J Kocsis, GV Bianchi, J Lu, J Vinholes, E Guardino, ... Journal of Clinical Oncology 31 (9), 1157-1163, 2013 | 461 | 2013 |
| Vascular integrin alpha (v) beta3: a new prognostic indicator in breast cancer. G Gasparini, PC Brooks, E Biganzoli, PB Vermeulen, E Bonoldi, LY Dirix, ... Clinical cancer research: an official journal of the American Association …, 1998 | 429 | 1998 |
| Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study E Van Cutsem, M Findlay, B Osterwalder, W Kocha, D Dalley, R Pazdur, ... Journal of Clinical Oncology 18 (6), 1337-1345, 2000 | 428 | 2000 |
| Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research … RJ Paridaens, LY Dirix, LV Beex, M Nooij, DA Cameron, T Cufer, ... Journal of Clinical Oncology 26 (30), 4883-4890, 2008 | 422 | 2008 |
| Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival IH Benoy, R Salgado, P Van Dam, K Geboers, E Van Marck, S Scharpé, ... Clinical Cancer Research 10 (21), 7157-7162, 2004 | 409 | 2004 |
| Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients LY Dirix, PB Vermeulen, A Pawinski, A Prove, I Benoy, C De Pooter, ... British journal of cancer 76 (2), 238-243, 1997 | 370 | 1997 |
| Docetaxel (TaxotereTM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group A Sulkes, J Smyth, C Sessa, LY Dirix, JB Vermorken, S Kaye, J Wanders, ... British journal of cancer 70 (2), 380-383, 1994 | 353 | 1994 |
| Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia PB Vermeulen, C Colpaert, R Salgado, R Royers, H Hellemans, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2001 | 337 | 2001 |
| Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent … D Miles, A Chan, G Romieu, LY Dirix, J Cortes, X Pivot, P Tomczak, ... Journal of clinical oncology 26 (15_suppl), LBA1011-LBA1011, 2008 | 320 | 2008 |
